|
Volumn 70, Issue 9, 2000, Pages 1404-1407
|
Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIBODY;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
LIVER ENZYME;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
VIRUS DNA;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG SAFETY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
ERYTHEMA;
GASTROINTESTINAL SYMPTOM;
GENE MUTATION;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
KIDNEY TRANSPLANTATION;
PARESTHESIA;
PRIORITY JOURNAL;
RECIPIENT;
VIRUS GENOME;
VIRUS REPLICATION;
|
EID: 0034669706
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/00007890-200011150-00024 Document Type: Article |
Times cited : (57)
|
References (11)
|